Targeted therapies to protect, restore, and repair the body
Rapid bench-to-bedside translation
Excellent safety profiles
Scalable GMP production
Synedgen designs glycopolymers to protect, repair and restore the body’s protective barriers. Applications cover a broad span of clinical modalities. Synedgen has previously developed therapeutics with unprecedented safety profiles in pulmonary, oral, wound, and ophthalmic applications.
Protecting the gastrointestinal (GI) tract from cancer therapy
Synedgen’s therapeutics have demonstrated efficacy across multiple modalities
October 19, 2021
SWM International’s Scapa Healthcare Business Signs Exclusive Technology Licensing Agreement for Novel Wound Care Technology with Synedgen, Inc.
August 5, 2021
Synedgen Initiates Clinical Trial Assessing Combination of SynePure and Catasyn for the Treatment of Partial Thickness Burns
February 18, 2021
Synedgen Appoints Industry Veteran Dennis Fenton, Ph.D., to Board of Directors